Navigation Links
CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Date:9/17/2007

VIENNA, Va., Sept. 17 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (AMEX: CVM) announces that its Chief Executive Officer, Geert Kersten, is a featured presenter at the Biotech/Pharma/Healthcare On-line Forum. The webcast presentation is scheduled for Tuesday, September 18, 2007 at 9:30 a.m. (Eastern Daylight Time) and can be accessed via the Internet at CEL-SCI's website http://www.cel-sci.com or http://www.investorcalendar.com/ClientPage.asp?ID=119627. If you are unable to participate during the live webcast, the call will be available for replay.

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine(R). In Phase II clinical trials Multikine was shown to be safe and well-tolerated, and to improve the patients' overall survival by 33% at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for a Phase III clinical trial with Multikine in January 2007 and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck in May 2007.

Multikine, a patented defined mixture of naturally derived cytokines, is the first immunotherapeutic agent in a new class of drugs called "Immune SIMULATORS". Immune SIMULATORS simulate the way our natural immune system acts in defending us against cancer. As opposed to other immunotherapies which are designed to target a single or limited number of specific antigens or molecules, Immune SIMULATORS are multi-targeted; they simultaneously cause a direct and targeted killing of t
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
2. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
3. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
4. The Past, Present and Future of HLA Typing
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)...  Express Scripts (NASDAQ: ESRX ) today ... Medicare ® Prescription Drug Plans (PDP) will offer ... WAG ) (NASDAQ: WAG ), helping ...  for their Medicare dollars. Medicare beneficiaries who ... or Choice plans for 2015 can save ...
(Date:10/1/2014)... , Oct. 1, 2014   Royal ... PHIA) today announced its eCareCoordinator and eCareCompanion telehealth ... Food and Drug Administration (FDA). A part of ... programs , eCareCoordinator and eCareCompanion are focused on ... first clinical applications to be available through the ...
(Date:10/1/2014)... 2014 Ardelyx, Inc. (NASDAQ: ... focused on cardio-renal, gastrointestinal and metabolic diseases, ... patient Phase 2b clinical trial evaluating tenapanor ... (IBS-C).  Results from this study demonstrated statistically ... symptoms for tenapanor-treated patients compared to patients ...
Breaking Medicine Technology:Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 3Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 4Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6
... Colo., Dec. 19, 2011   LABS, Inc., a global, ... expertise in regulated testing for human organs, cells, tissues ... named Company of the Year by the 2011 Colorado ... and honors individuals and companies that have made a ...
... Accuray Incorporated (Nasdaq: ARAY ), the ... medical centers globally have installed both a CyberKnife ... System enabling the delivery of personalized treatment for the ... smaller community sites in rural areas, mid-sized regional hospitals ...
Cached Medicine Technology:LABS, Inc. Named Colorado's Bioscience Company of the Year 2LABS, Inc. Named Colorado's Bioscience Company of the Year 3Medical Centers Worldwide Adopt Both Accuray's CyberKnife and TomoTherapy Systems 2Medical Centers Worldwide Adopt Both Accuray's CyberKnife and TomoTherapy Systems 3Medical Centers Worldwide Adopt Both Accuray's CyberKnife and TomoTherapy Systems 4
(Date:10/1/2014)... Journal of the American Medical Association shows ... or severe chronic knee pain, acupuncture did not provide ... randomly assigned 282 patients (50 years or older) with ... pretend laser treatment. , Treatments were delivered for ... and sham (inactive) laser acupuncture. , Researcher Professor Kim ...
(Date:10/1/2014)... New research suggests the adage that encourages people to ... target when it comes to exercise. When walking, staying ... distance to it appear shorter and help people walk ... compares this technique to walking while looking around the ... quality of exercise. , "People are less interested in ...
(Date:10/1/2014)... Lifeinsurance-policy.com has released a new blog post explaining how ... , Smoking will always have a negative impact on ... method to find affordable coverage. Insurance brokerage websites specialize ... , Whole life insurance premiums will be fixed throughout ... is permanent, the initial rates are very important. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Join the more ... Eating Disorder Treatment Center’s first ever charity golf tournament to ... people with eating disorders who cannot afford treatment. The tournament ... Club in Eureka, Mo. , The day-long event starts ... A reception and award dinner will begin at 5 p.m. ...
(Date:10/1/2014)... 01, 2014 Diet Doc understands that many ... lose weight and their dieting attempts could be easily sabotaged ... hormone diet treatments into their programs as a ... see fast and effective weight loss results, it also allows ... habits to maintain their weight for the future. , Earlier ...
Breaking Medicine News(10 mins):Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
... United Kingdom and hires Michael Dyson to run European operations. ... ... DNA2.0, the leading gene synthesis and protein engineering company, today announced ... the United Kingdom-based DNA2.0 Ltd. Michael Dyson, PhD, has been appointed ...
... May help avoid incorrect Breast Cancer diagnosis and management ... 10 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: ... provisional patent application that describes a new simplified method ... application was filed with the United States Patent and ...
... 10 Prime Therapeutics LLC (Prime),announces that it has ... Montana,(BCBSMT) to provide commercial pharmacy benefit management services, beginning,January ... Prime will provide pharmacy benefit services to more than ... drug coverage. The,three-year contract covers a range of pharmacy ...
... these medications may be reason, study suggests , , TUESDAY, ... prescription drugs, primarily pain relievers, appear to be ... suggests. , West Virginia, in particular, has seen a ... who have uncovered patterns of "doctor shopping" for drugs ...
... Award-Winning Recording Artist Toni Braxton and Her Son Featured in ... NEW YORK, Dec. 10 The Advertising Council, in ... new series of public service advertisements (PSAs) featuring Grammy award-winning ... raise awareness about autism and to urge parents to learn ...
... be faced with a national health care crisis in the ... a growing number of older adults find themselves diagnosed with ... of a team of researchers from across the country who ... older patients at risk of or dealing with cancer are ...
Cached Medicine News:Health News:DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations 2Health News:PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers 2Health News:PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers 3Health News:Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client 2Health News:Painkillers Linked to Increase in Overdose Deaths 2Health News:Painkillers Linked to Increase in Overdose Deaths 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 4Health News:Surge in older cancer survivors expected as baby boomers age 2Health News:Surge in older cancer survivors expected as baby boomers age 3
... an interventional guidance device that uses ... the accuracy of computed tomography (CT)-guided ... accuracy, SimpliCT® also has the potential ... puncture procedures including biopsies and fluid ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
... QuadraLase™ is a unique ... cap that may be rotated ... positions: like having four fibers ... be used for vaporization and ...
... the first truly lateral, all quartz fiber. ... (NA) compression technology for Total Internal Reflection ... The resulting output is virtually indistinguishable from ... transmission efficiency in a round spot of ...
Medicine Products: